SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-093314
Filing Date
2021-03-25
Accepted
2021-03-25 06:35:00
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d150630ds3.htm S-3 356317
2 EX-1.2 d150630dex12.htm EX-1.2 215693
3 EX-4.4 d150630dex44.htm EX-4.4 316515
4 EX-5.1 d150630dex51.htm EX-5.1 30778
5 EX-5.2 d150630dex52.htm EX-5.2 6243
6 EX-23.1 d150630dex231.htm EX-23.1 1696
7 EX-23.2 d150630dex232.htm EX-23.2 1494
8 GRAPHIC g150630g36i06.jpg GRAPHIC 27684
9 GRAPHIC g150630sp102.jpg GRAPHIC 9188
  Complete submission text file 0001193125-21-093314.txt   975373
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254684 | Film No.: 21770073
SIC: 2834 Pharmaceutical Preparations